{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Aytu BioPharma, Inc. "},"Symbol":{"label":"Symbol","value":"AYTU"},"Address":{"label":"Address","value":"7900 E. UNION AVENUE,SUITE 920 SUITE 920, DENVER, Colorado, 80237, United States"},"Phone":{"label":"Phone","value":"+1 720 437-6580"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan."},"CompanyUrl":{"label":"Company Url","value":"https://www.aytubio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Margaret Cabano","title":"Vice President-Operations"},{"name":"Russell Lee McMahen","title":"Senior Vice President-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}